EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX)

11 filings reported holding EPRX - EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value as of Q3 2024.
EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.8M shares of 51M outstanding shares and own 3.53% of the company stock.
Largest 10 shareholders include SCOTIA CAPITAL INC. (1.4M shares), Royal Bank of Canada (271K shares), BANK OF MONTREAL /CAN/ (49.3K shares), GOLDMAN SACHS GROUP INC (34.5K shares), UBS Group AG (33K shares), 180 WEALTH ADVISORS, LLC (13K shares), TD Waterhouse Canada Inc. (1.5K shares), NATIONAL BANK OF CANADA /FI/ (150 shares), Federation des caisses Desjardins du Quebec (0 shares), and JPMORGAN CHASE & CO (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.